plasmid vaccine

Known as: plasmid vaccines, plasmids vaccines, vector vaccine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been causally associated with fetal… (More)
  • figure 2
  • figure 3
  • figure 5
  • figure 4
  • figure 6
Is this relevant?
2016
2016
IMPORTANCE Developing effective vaccines against Ebola virus is a global priority. OBJECTIVE To evaluate an adenovirus type 26… (More)
Is this relevant?
2011
2011
In vivo electroporation (EP) has proven to significantly increase plasmid transfection efficiency and to augment immune responses… (More)
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2010
2010
Tuberculosis (TB) remains a threat to global health. While advances in diagnostics and treatment are crucial to the containment… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Nineteen patients with stage IV melanoma were treated in an escalating dose, phase 1 trial of a DNA plasmid vaccine pSEM. The… (More)
Is this relevant?
2006
2006
The Vaccine Research Center has developed a number of vaccine candidates for different diseases/infectious agents (HIV-1, Severe… (More)
  • table 1
  • figure 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Many candidate vaccines are effective in animal models of genital herpes simplex virus type 2 (HSV-2) infection. Among them… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
Gene transfer vectors based on recombinant adeno-associated virus (rAAV) are simple, versatile, and safe. While the conventional… (More)
Is this relevant?
1999
1999
The broad objective of the research presented here is to develop a noncatalytic plasmid maintenance system for the stabilization… (More)
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
We converted a model, syngeneic, nonimmunogenic tumor antigen into a vaccine by fusing it with a proinflammatory chemokine. Two… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?